Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01114815 · ClinicalTrials.gov registry record

Research Study on Cerebral Autosomal Dominant Arteriopathy With Subcortical Infarcts and Leukoencephalopathy (CADASIL)

A clinical trial, sponsored by NYU Langone Health.

Completed
Registry status
100
Enrollment target

NCT01114815 is a clinical trial that has completed, run by NYU Langone Health. The registered enrollment target is 100 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01114815 has completed, sponsored by NYU Langone Health.

COMPLETED
Registry status
100 participants
Enrollment target

Study Summary

The purpose of this study is to delineate early neurological features and their progression in patients with cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL) in order to facilitate early diagnosis, prevent erroneous diagnosis and mistreatment and improve physician education about this relatively common yet under-recognized dementing disorder. Patients with CADASIL suffer from a variant from migraine that differs from wild type migraine in terms of its severity, progressive nature and underlying pathophysiology. Recurrent stereotypic acute confusional state associated with the headache episodes in patients with CADASIL is a distinctive phenomenon, which if recognized will lead to an earlier and accurate diagnosis of this condition. Specific Aims: * Characterize the nature, frequency and severity of migraine in patients with CADASIL. * Delineate the phenomenon of acute confusional migraine as a distinct subgroup of migraine and establish its prevalence in patients with CADASIL. * Determine the latency between the onset of neurological symptoms including migraine, and diagnosis of CADASIL and the prevalence of misdiagnosis.

Trial Details

FieldValue
Enrollment Target 100 participants
Start Date 2009-03
Est. Completion 2012-03

Sponsor

NYU Langone Health

1,164 total trials

What the Registry Record Tells You About NCT01114815

The ClinicalTrials.gov registry entry for NCT01114815 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 100 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is NYU Langone Health, which has 1,164 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 0 interventions.

NCT01114815 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT01114815 about?

NCT01114815 is a clinical study titled "Research Study on Cerebral Autosomal Dominant Arteriopathy With Subcortical Infarcts and Leukoencephalopathy (CADASIL)". The purpose of this study is to delineate early neurological features and their progression in patients with cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL) in order to facilitate early diagnosis, prevent erroneous diagnosis and mistreatment and i...

What is the current status of trial NCT01114815?

This trial is currently completed. The enrollment target is 100 participants. The study started on 2009-03. Estimated completion is 2012-03.

Who is sponsoring clinical trial NCT01114815?

This trial is sponsored by NYU Langone Health, which has 1,164 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.